Trial Sequential Analysis is a frequentist method to help researchers control the risks of random errors in meta-analyses (1). Fisher and colleagues used Trial Sequential Analysis on cell therapy for heart diseases (2). The present article discusses the usefulness of Trial Sequential Analysis and its dependence on the choice of the parameters for calculation of the required information size and the adjacent monitoring boundaries, and comments on the approach by Fisher et al. (2).

Comment on: "Cell Therapy for Heart Disease: Trial Sequential Analyses of Two Cochrane Reviews" / G. Castellini, E.E. Nielsen, C. Gluud. - In: CLINICAL PHARMACOLOGY & THERAPEUTICS. - ISSN 0009-9236. - 102:1(2017 Jul), pp. 21-24. [10.1002/cpt.536]

Comment on: "Cell Therapy for Heart Disease: Trial Sequential Analyses of Two Cochrane Reviews"

G. Castellini
Primo
;
2017

Abstract

Trial Sequential Analysis is a frequentist method to help researchers control the risks of random errors in meta-analyses (1). Fisher and colleagues used Trial Sequential Analysis on cell therapy for heart diseases (2). The present article discusses the usefulness of Trial Sequential Analysis and its dependence on the choice of the parameters for calculation of the required information size and the adjacent monitoring boundaries, and comments on the approach by Fisher et al. (2).
Trial Sequential Analysis; cardiovascular diseases; stem cells
Settore MED/42 - Igiene Generale e Applicata
lug-2017
11-ott-2016
Article (author)
File in questo prodotto:
File Dimensione Formato  
Castellini_et_al-2016-Clinical_Pharmacology_&_Therapeutics.pdf

accesso riservato

Tipologia: Publisher's version/PDF
Dimensione 315.29 kB
Formato Adobe PDF
315.29 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Castellini_et_al-2017-Clinical_Pharmacology_&_Therapeutics.pdf

accesso riservato

Tipologia: Publisher's version/PDF
Dimensione 307.89 kB
Formato Adobe PDF
307.89 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/465230
Citazioni
  • ???jsp.display-item.citation.pmc??? 37
  • Scopus 38
  • ???jsp.display-item.citation.isi??? 18
social impact